Navigation Links
The 60 Plus Association Asks Congressional Leaders To Weigh In Against Controversial Health Care Merger
Date:2/14/2012

ALEXANDRIA, Va., Feb. 14, 2012 /PRNewswire/ -- The 60 Plus Association (60 Plus) today sent a letter asking Congressional leaders to weigh in with the Federal Trade Commission (FTC) against the proposed merger between Express Scripts, Inc. (ESI) and Medco Health Solutions, two pharmacy benefit managers (PBMs) that administer prescription benefits for many health plans, including some Medicare Part D plans. 60 Plus is a non-partisan seniors advocacy group, with over 7.1 million supporters. 

In the letter, 60 Plus expressed concerns about the impact of an approved merger on our nation's seniors, in particular, telling Congressional leaders it will, 'hurt our members and your constituents.'

"It is important to remember that seniors tend to have more chronic conditions and take more medications than other age groups, and are especially sensitive to changes in the pharmaceutical-drug sector of the health market," the letter states. "For seniors, the ESI/Medco merger will mean higher prescription prices, fewer choices in pharmacy care, and lower-quality health services than are currently available."

If the merger is approved, the combined ESI/Medco will control prescription drug benefits for more than 100 million Americans, and more than 50 percent of several important components of the pharmacy market, including specialty pharmaceuticals and mail-order. According to 60 Plus, this level of monopolistic control will eventually result in higher prices for all consumers and fewer choices in pharmacy care for seniors – especially those living in rural or underserved urban areas where there are few other options.

"Approving this merger will result in higher prices, loss of pharmacy choices and lower-quality services for America's seniors," said Jim Martin, 60 Plus Association Chairman. "This merger is anti-competitive, anti-consumer and anti-senior, and should not be allowed to proceed.

"The 60 Plus Association strongly suppo
'/>"/>

SOURCE 60 Plus Association
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
2. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
3. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
4. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
5. American Fertility Association Calls for Expanded Research to Advance New Technology to Screen Embryos for Genetic Abnormalities
6. Actress and Mother Jennifer Garner Joins American Lung Association to Encourage Americans to Get an Influenza Vaccination
7. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
8. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
9. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
10. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
11. MedicAlert Foundation Joins The Alzheimers Association to Offer MedicAlert(R) + Alzheimers Association Safe Return(R) - Live 24-Hour Emergency Response for Wandering and Medical Emergencies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... May 4, 2015 Southfield Capital, ... firm, announced today that it completed a ... Communications. BioPharm specializes in the development and multi-channel ... pharmaceutical and biotechnology industries. Through ... shareholders half of their invested capital and ...
(Date:5/4/2015)... -- PharmaEngine, Inc. (TWO:4162) today announced that its ... ) with its sublicensing partner, Baxter International Inc. ... has submitted a marketing authorization application (MAA) to ... liposome injection), also known as "nal-IRI," in patients ... been previously treated with gemcitabine-based therapy. ...
(Date:5/4/2015)... DENVER , May 4, 2015  By ... now possible to distinguish between two very different ... to Theodore Henderson , MD, PhD., a ... diagnosing complex cases, this study can ... differences, and therefore treatment options, for Post-Traumatic Stress ...
Breaking Medicine Technology:Southfield Capital and BioPharm Communications Announce Dividend Recapitalization 2PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 2PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 3New Medical Research Shows Brain Imaging Can Now Help Doctors Differentiate Between PTSD and Traumatic Brain Injuries 2New Medical Research Shows Brain Imaging Can Now Help Doctors Differentiate Between PTSD and Traumatic Brain Injuries 3
... Holdings, Inc., (NYSE: HRC ) invites you ... Suisse,s 2011 Healthcare Conference in Phoenix on November 9, ... invited to listen to the live discussion via the ... directly at http://cc.talkpoint.com/cred001/110911a_ah/?entity=1_CIKQF3F .  A recorded replay of ...
... Epilepsy Therapy Project (ETP), a non-profit organization whose mission ... epilepsy and seizures and the parent organization of epilepsy.com, ... inviting entries that represent the most innovative ideas in ... Shark Tank competition will receive national recognition and a ...
Cached Medicine Technology:Epilepsy Therapy Project Announces "Shark Tank" Competition to Identify the Most Innovative, New Products for People with Epilepsy 2Epilepsy Therapy Project Announces "Shark Tank" Competition to Identify the Most Innovative, New Products for People with Epilepsy 3
(Date:5/4/2015)... The National Association of Professional Women ... 2015-2016 inductee into its VIP Woman of the Year ... leadership in business. NAPW is the nation's leading networking ... members and over 200 operating Local Chapters. , “I'm ... NAPW President Star Jones. “Her perseverance, work ethic and ...
(Date:5/4/2015)... Friday afternoon at A Forever Recovery, a result-driven substance ... staff gather in the common room to celebrate the ... gain encouragement and inspiration in their continuing effort to ... patients who have completed their recovery programs come to ... a bit about their journey with the audience. Some ...
(Date:5/4/2015)... 2015 HHT is a rare but ... While it can have seemingly mild symptoms like frequent ... Hereditary Hemorrhagic Telangiectasia (HHT) is a hereditary disorder ... normal capillary connections between an artery and a vein. ... nosebleeds, but may also be present in the lungs, ...
(Date:5/4/2015)... York, New York (PRWEB) May 04, 2015 ... much as $2.4 billion to settle thousands of Actos ... 2 diabetes medication increases the risk that a patient ... issued on April 28th, if 95% of those eligible ... will resolve nearly 9,000 bladder cancer cases currently pending ...
(Date:5/4/2015)... “ LiveSchool ” was featured on NewsWatch as part ... the latest and coolest applications on the market for ... AppWatch and technology expert, conducted the app review and ... reward students with good behavior. , Positive re-enforcement is ... And the good people at LiveSchool have taken ...
Breaking Medicine News(10 mins):Health News:NAPW Inducts Patti Hommes, Director of Advancement Services, Springside Chestnut Hill Academy, a 2015-2016 Professional Woman of the Year Circle 2Health News:A Forever Recovery Celebrates New Victories in Overcoming Addiction With Weekly Graduation 2Health News:Frequent Nosebleeds Can Be a Sign of a Rare Undiagnosed Disease - Cure HHT 2Health News:Frequent Nosebleeds Can Be a Sign of a Rare Undiagnosed Disease - Cure HHT 3Health News:Actos Lawsuit Settlement: Takeda Pharmaceutical Co. to Pay As Much As $2.4 Billion to Resolve Claims Alleging Actos Causes Bladder Cancer 2Health News:Actos Lawsuit Settlement: Takeda Pharmaceutical Co. to Pay As Much As $2.4 Billion to Resolve Claims Alleging Actos Causes Bladder Cancer 3Health News:An Application for Teachers to Reward Students with Good Behavior Was Featured on NewsWatch Television 2
... ... ... ... ...
... ... ... , ... ...
... ... ... ... ...
... shown to be effective in breast cancer packs an effective ... a specific genetic mutation, a study at UCLA,s Jonsson Comprehensive ... when given together proved to significantly inhibit tumor growth in ... mutation that results in an aggressive form of the disease, ...
... scientists studying acute forms of Leukaemia have identified a new ... the growth of diseased cells. The research, reported in ... to genes, which if targeted could prevent diseased cells from ... the University of Vienna, carried out their research on acute ...
... bone mineral density, strength and postural balance due to ... group of women but also for elderly men, says ... and continues "It is well known that the risk ... result of weaker bones, poorer balance and attenuated ability ...
Cached Medicine News:Health News:AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 2Health News:AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 3Health News:AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 4Health News:AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 5Health News:AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 6Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 2Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 3Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 4Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 5Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 6Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 7Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 8Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 9Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 10Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 11Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 12Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 13Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 14Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 15Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 16Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 17Health News:Marketech Celebrates 25 Years of Service 2Health News:Marketech Celebrates 25 Years of Service 3Health News:Marketech Celebrates 25 Years of Service 4Health News:Marketech Celebrates 25 Years of Service 5Health News:Herceptin and Tykerb effective against a subset of gastric cancers 2Health News:Herceptin and Tykerb effective against a subset of gastric cancers 3Health News:Targeting leukemia cell's gene 'addiction' presents new strategy for treatment 2Health News:Soccer reduces risk of falls and bone fractures 2Health News:Soccer reduces risk of falls and bone fractures 3
... Optima L-XP ultracentrifuge is designed ... the discovery process if research involves ... a sophisticated on-board computer, enhanced firmware, ... easy-to-use touch screen, Optima L-XP delivers ...
... With the ability to provide a simple, ... in lipemic samples), the Airfuge CLS delivers ... can be cleaned in 10 minutes, eliminating ... tabletop centrifuge: Reaches top speed in as ...
... integrated chemistry system brings versatility in ... smaller laboratory. A model of innovation ... chemistry system features state-of-the-art Dimension testing ... environment, in a flexible. affordable, easy-to-use ...
The Dimension RxL Max is an integrated chemistry system and is the most powerful and technologically advanced Dimension analyze with new standard for excellence in clinical diagnostics. Simply put, t...
Medicine Products: